Putnam BioRevolution ETF Rating $28.58 -0.24 (-0.83%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$28.56 -0.02 (-0.07%) As of 07/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.80Holdings in SYNB have an aggregate rating of Moderate Buy based on 501 analyst ratings issued in the past year covering 32 companies (92.9% of the portfolio).SYNB Aggregate Price Target$28.58High Prediction$28.58Average Prediction$28.58Low Prediction$28.58Holdings in SYNB have an aggregate price target of $28.58 and a range of $28.58 to $28.58 covering 32 companies (92.9% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.92%TMOThermo Fisher Scientific$415.29-2.3%4.9931 of 5 stars2.80$599.30 44.3%20Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision6.38%CTVACorteva$73.05-0.2%4.2338 of 5 stars2.80$77.38 5.9%15Positive NewsAnalyst Forecast6.09%NVZMYNovozymes A/S$69.93-0.5%2.5783 of 5 stars3.0035.19%ABBVAbbVie$189.26-1.1%4.8242 of 5 stars2.81$211.29 11.6%27Trending NewsEx-DividendAnalyst Revision4.80%BIOBio-Rad Laboratories$246.31-1.3%4.6844 of 5 stars2.75$324.25 31.6%44.75%NVDANVIDIA$172.41-0.3%4.5082 of 5 stars2.95$181.22 5.1%42Trending NewsAnalyst ForecastInsider TradeAnalyst Revision4.46%AZNAstraZeneca$68.79-0.7%3.9403 of 5 stars2.83$89.00 29.4%6Trending NewsAnalyst Revision4.29%ASNDAscendis Pharma A/S$169.90-4.1%3.6182 of 5 stars3.00$223.07 31.3%15Positive News4.03%ZTSZoetis$148.61-0.9%4.958 of 5 stars2.70$204.63 37.7%10Trending NewsAnalyst DowngradeAnalyst Revision3.82%LLYEli Lilly and Company$771.78+1.3%4.9771 of 5 stars2.75$1,012.56 31.2%20Trending News3.62%CDNSCadence Design Systems$315.57-1.6%4.55 of 5 stars2.79$330.07 4.6%14Positive News3.31%DDDuPont de Nemours$75.57+1.5%4.6762 of 5 stars2.77$88.15 16.7%13News CoveragePositive NewsAnalyst Forecast3.18%DHRDanaher$189.98-2.5%4.9641 of 5 stars2.85$248.48 30.8%20Positive NewsUpcoming EarningsAnalyst Forecast2.92%REGNRegeneron Pharmaceuticals$542.52-1.4%4.8137 of 5 stars2.80$814.57 50.1%252.84%ICLRIcon$143.54-2.3%4.3229 of 5 stars2.60$198.08 38.0%15Upcoming Earnings2.79%DARDarling Ingredients$35.85+0.6%4.3758 of 5 stars3.00$46.14 28.7%8Positive NewsUpcoming Earnings2.57%ONONON$53.14-2.0%3.04 of 5 stars3.00$63.85 20.2%22Positive News2.36%NGVTIngevity$46.16-0.3%2.8861 of 5 stars2.75$55.25 19.7%4Positive News2.33%AVTRAvantor$13.294.9167 of 5 stars2.42$18.14 36.5%12Positive News2.12%TECHBio-Techne$52.02-2.4%4.8701 of 5 stars2.50$70.00 34.6%12Analyst Revision2.06%BNBrookfield$67.30-1.2%3.1267 of 5 stars2.86$66.13 -1.7%7Positive News1.66%PPGPPG Industries$114.51-1.3%4.7096 of 5 stars2.53$131.42 14.8%15News CoveragePositive NewsDividend IncreaseAnalyst ForecastAnalyst RevisionHigh Trading Volume1.66%ARGXargenex$564.59-1.4%4.4839 of 5 stars3.10$728.06 29.0%21Positive NewsAnalyst Revision1.54%VRTXVertex Pharmaceuticals$459.81-0.7%4.7221 of 5 stars2.54$511.71 11.3%28Positive NewsAnalyst Revision1.47%BMRNBioMarin Pharmaceutical$57.29-1.9%4.9878 of 5 stars2.75$93.78 63.7%24News CoveragePositive NewsAnalyst ForecastAnalyst Revision1.42%ALNYAlnylam Pharmaceuticals$320.53-1.3%4.1351 of 5 stars2.80$346.13 8.0%25News CoverageAnalyst ForecastAnalyst Revision1.10%BIIBBiogen$124.99-2.9%4.9145 of 5 stars2.38$188.48 50.8%32Trending NewsInsider TradeAnalyst Revision1.05%BGBunge Global$74.46+1.8%4.2352 of 5 stars2.40$81.60 9.6%5Positive News0.87%SANBanco Santander$8.42-1.1%3.2628 of 5 stars3.004Upcoming Earnings0.57%LEGNLegend Biotech$41.59-1.3%3.6925 of 5 stars2.91$73.33 76.3%11News CoveragePositive NewsAnalyst ForecastAnalyst Revision0.41%ABSIAbsci$3.12+8.3%2.1827 of 5 stars3.00$8.40 169.2%5High Trading Volume0.35%CRSPCRISPR Therapeutics$65.13+18.2%2.9204 of 5 stars2.53$71.75 10.2%17Positive NewsInsider TradeAnalyst RevisionGap UpHigh Trading Volume This page (NYSEARCA:SYNB) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
